Evidence map›Paper›PMID 28827991›Full record

ArticleEXCLI journal2017

Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures.

Gaurav Gupta, Rajiv Dahiya, Kamal Dua, Dinesh Kumar Chellappan, Juhi Tiwari, Ganesh Narayan Sharma, Santosh Kumar Singh, Anurag Mishra, Rakesh Kumar Sharma, Mohit Agrawal

Open access · greenAbstract read
In one paragraph

Article in EXCLI journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Liraglutide Protects Against Brain Amyloid-βInternational journal of molecular sciences · 2020
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Gaurav GuptaSchool of Pharmacy, Jaipur National University, Jagatpura 302017, Jaipur, India.
Rajiv DahiyaLaboratory of Peptide Research and Development, School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad & Tobago, West Indies.
Kamal DuaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia.
Dinesh Kumar ChellappanDepartment of Life Science, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.
Juhi TiwariSchool of Pharmacy, Jaipur National University, Jagatpura 302017, Jaipur, India.
Ganesh Narayan SharmaSchool of Pharmacy, Jaipur National University, Jagatpura 302017, Jaipur, India.
Santosh Kumar SinghSchool of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Jaipur, India.
Anurag MishraSchool of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Jaipur, India.
Rakesh Kumar SharmaSchool of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Jaipur, India.
Mohit AgrawalSchool of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Jaipur, India.
Gyan Vihar University · INUniversity of Technology Sydney · AUUniversity of the West Indies · TT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28827991
PMCPMC5547386
OpenAlexW2803061811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.